We further evaluated the expression levels of CD69 and functional molecules produced by CD8+ T-TILs, including IFN-γ, TNF-α, IL-2, granzyme B and perforin, in previously described DLBCL patients. The gene discussed is CD69; the disease is diffuse large B-cell lymphoma.